Use of Glucagon-like peptide 2 (GLP-2) analogs in inflammatory bowel disease
Introduction: Inflammatory bowel disease (IBD) is a chronic condition that involves long-term treatment and chronic idiopathic inflammation within the gastrointestinal tract. The predominant forms of IBD are: Crohn's disease and ulcerative colitis. These diseases cause significant physical as w...
Saved in:
Main Authors: | Dobromiła Osuch (Author), Piotr Zatyka (Author), Adam Słomczyński (Author), Agata Pawłowska (Author), Michal Rabenda (Author), Piotr Janik (Author), Dominika Opala (Author) |
---|---|
Format: | Book |
Published: |
Nicolaus Copernicus University in Toruń,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glucagon-like peptide-1 receptor agonists and derivatives in the treatment of obesity - review
by: Michal Rabenda, et al.
Published: (2024) -
Effects of Isotretinoin treatment on human body - review
by: Adam Słomczyński, et al.
Published: (2024) -
Anti-inflammatory effects of selected dietary components on endometriosis - review
by: Agata Pawłowska, et al.
Published: (2024) -
Vitamin B12 (cobalamin) deficiency in gastroenterological diseases - review
by: Piotr Zatyka, et al.
Published: (2024) -
Glucagon-like peptide 1 (GLP-1)
by: T.D. Müller, et al.
Published: (2019)